Summit Global Investments Buys 12,991 Shares of Colgate-Palmolive Company $CL

Summit Global Investments raised its stake in Colgate-Palmolive Company (NYSE:CL) by 12.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 116,574 shares of the company’s stock after buying an additional 12,991 shares during the period. Colgate-Palmolive makes up about 0.5% of Summit Global Investments’ investment portfolio, making the stock its 25th biggest position. Summit Global Investments’ holdings in Colgate-Palmolive were worth $9,946,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. State Street Corp increased its position in shares of Colgate-Palmolive by 97.4% during the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after acquiring an additional 46,476,510 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Colgate-Palmolive by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after purchasing an additional 1,010,872 shares during the period. First Eagle Investment Management LLC boosted its holdings in shares of Colgate-Palmolive by 1.1% in the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after purchasing an additional 88,917 shares during the period. Amundi grew its stake in Colgate-Palmolive by 19.9% in the second quarter. Amundi now owns 6,218,257 shares of the company’s stock worth $570,090,000 after purchasing an additional 1,033,918 shares in the last quarter. Finally, Bank of America Corp DE bought a new position in Colgate-Palmolive in the second quarter worth approximately $567,483,000. 80.41% of the stock is currently owned by institutional investors.

Insider Transactions at Colgate-Palmolive

In related news, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the sale, the chief operating officer directly owned 64,901 shares in the company, valued at $5,974,137.05. This represents a 13.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Noel Wallace sold 161,021 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the sale, the chief executive officer directly owned 362,231 shares in the company, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 175,191 shares of company stock valued at $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on CL shares. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating on the stock in a report on Monday, October 5th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 target price (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Royal Bank Of Canada reissued an “outperform” rating and set a $104.00 price target on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Bank of America cut their price target on Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating on the stock in a research note on Friday, October 9th. Finally, Morgan Stanley restated an “overweight” rating and issued a $104.00 price objective (up from $100.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $98.56.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $95.35 on Friday. The firm has a market cap of $76.01 billion, a price-to-earnings ratio of 37.39, a PEG ratio of 4.61 and a beta of 0.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The company’s 50 day moving average is $89.54 and its 200 day moving average is $89.65.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. Colgate-Palmolive’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.89 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is presently 84.13%.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
• Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
• Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
• Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.